Giant Eagle may be known for its groceries, but it also has stepped into one of the fastest growing areas for prescription medication dispensing: the specialty pharmacy.
This spring, the O’Hara grocery chain expanded its services for processing and dispensing prescriptions for treating complex conditions such as autoimmune diseases, hepatitis C and HIV — moving into a 35,000-square-foot space in Moon where teams help customers and providers navigate the sometimes-tricky waters of specialty pharmacy.
In many respects, the actual dispensing is only a small part of the operation.
Mark Doerr, senior vice president for Giant Eagle pharmacy services, said the company has organized teams to work with customers. Each team has its own pharmacist, nurse and pharmacy technician, as well as someone to help verify customers’ insurance benefits. A dietitian is also available for phone consultations.
Each team specializes in one of six therapies: hepatitis-C, autoimmune conditions, oncology, organ transplantation, multiple sclerosis or HIV, and they are all cross trained to handle conditions that do not fall into one of those categories.
All that support is necessary to help patients stay on track while they are taking medications that may range in cost from several hundred dollars a month to $80,000 for a 12-week course of a new drug that cures hepatitis C.
Just as importantly, Mr. Doerr added, it will help customers and providers with the necessary pre-authorization protocols, make sure everyone understands the customers’ deductible, co-payment and co-insurance obligations, and counsel them if financial assistance is needed.
“We don’t want there to be a financial reason why patients don’t take their medicine,” said Chris Kloc, Giant Eagle’s senior director for specialty pharmacy.
Once all of that is arranged, customers may pick up the medication at their local Giant Eagle pharmacy, or have it delivered to their home at no extra charge.
By expanding its specialty pharmacy offerings, Giant Eagle is tapping into a market that has been growing as much as 20 percent to 25 percent annually by some estimates. Many of the new U.S. Food and Drug Administration approvals are for specialty drugs, with 19 of 28 medicines approved in 2013 falling into the specialty category.
Meanwhile, more and more traditional medications now have lower cost, and lower margin, generic alternatives.
“Some experts believe the specialty pharmacy is the future of pharmacy, and if you’re not moving in that direction, then you don’t have a future,” said Robert Fulcher, COO of the National Association of Specialty Pharmacy in Alexandria, Va.
The move by grocery retailers into specialty pharmacy is a comparatively new one; Mr. Fulcher said he believes Kroger in Florida was the first to acquire a specialty pharmacy business in 2012.
Giant Eagle, which operates 219 in-store pharmacies, made its own acquisition in December 2013, buying Rx21 Specialty Pharmacy of Cleveland. Bringing that service in-house now, as Giant Eagle is doing, “is a little bit out of the norm,” Mr. Fulcher said, “but it is not surprising.”
Mr. Doerr said he expects the specialty pharmacy operation to be profitable but declined to offer specifics.
One indication of the market’s prospects may be found with Diplomat Pharmacy Inc. of Michigan, which bills itself as “the nation’s largest independent specialty pharmacy in the United States.”
In its 2014 annual report filing with the Securities and Exchange Commission, Diplomat officials reported $4.8 million in net income on $2.2 billion in sales, up from $1.5 billion in sales the year before.
By one estimate, spending on specialty medications industry wide has increased by $54 billion in the last five years and represents 73 percent of overall growth in medicine-related spending.
For now, big players such as CVS Caremark, Express Scripts and Walgreen Co. still control the lion’s share of the specialty drug market. But, with specialty drugs expected to make up half of all prescription drug spending by 2020, more companies may soon be tempted to join Giant Eagle.
Steve Twedt: stwedt@post-gazette.com or 412-263-1963.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.